KR20010022741A - 신규 노화-인자 유전자, ｐ23의 단리 - Google Patents

신규 노화-인자 유전자, ｐ23의 단리 Download PDF

Info

Publication number
KR20010022741A
KR20010022741A KR1020007001338A KR20007001338A KR20010022741A KR 20010022741 A KR20010022741 A KR 20010022741A KR 1020007001338 A KR1020007001338 A KR 1020007001338A KR 20007001338 A KR20007001338 A KR 20007001338A KR 20010022741 A KR20010022741 A KR 20010022741A
Authority
KR
South Korea
Prior art keywords
cells
cell
ala
nucleic acid
leu
Prior art date
Application number
KR1020007001338A
Other languages
English (en)
Korean (ko)
Inventor
스위스헬름카렌
호시에르스잔느
쿠베스만프레드
Original Assignee
엘. 데이예를 카렌.
유니버시티 오브 워싱톤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 엘. 데이예를 카렌., 유니버시티 오브 워싱톤 filed Critical 엘. 데이예를 카렌.
Publication of KR20010022741A publication Critical patent/KR20010022741A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
KR1020007001338A 1997-08-08 1998-08-05 신규 노화-인자 유전자, ｐ23의 단리 KR20010022741A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90887397A 1997-08-08 1997-08-08
US08/908,873 1997-08-08
PCT/US1998/016343 WO1999007893A1 (en) 1997-08-08 1998-08-05 ISOLATION OF A NOVEL SENESCENCE-FACTOR GENE, p23

Publications (1)

Publication Number Publication Date
KR20010022741A true KR20010022741A (ko) 2001-03-26

Family

ID=25426353

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020007001338A KR20010022741A (ko) 1997-08-08 1998-08-05 신규 노화-인자 유전자, ｐ23의 단리

Country Status (9)

Country Link
EP (1) EP1012333A4 (de)
JP (1) JP2001512698A (de)
KR (1) KR20010022741A (de)
CN (1) CN1270637A (de)
AU (1) AU8693598A (de)
BR (1) BR9811865A (de)
CA (1) CA2296598A1 (de)
TR (1) TR200000331T2 (de)
WO (1) WO1999007893A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002024721A1 (en) * 2000-09-20 2002-03-28 Human Genome Sciences, Inc. 21 human secreted proteins
EP1248839B1 (de) * 2000-01-21 2010-04-07 Polymun Scientific Immunbiologische Forschung GmbH Tumor- und seneszenzsmarker
AU750296B2 (en) 2000-06-23 2002-07-11 F. Hoffmann-La Roche Ag Antibodies against SEMP1, methods for their production and uses thereof
WO2002101075A2 (en) 2001-06-13 2002-12-19 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
AU2009248945B2 (en) 2008-05-23 2014-02-13 Siwa Corporation Methods, compositions and apparatuses for facilitating regeneration
US9649376B2 (en) 2010-09-27 2017-05-16 Siwa Corporation Selective removal of age-modified cells for treatment of atherosclerosis
US8721571B2 (en) 2010-11-22 2014-05-13 Siwa Corporation Selective removal of cells having accumulated agents
CN107001459B (zh) 2014-09-19 2021-11-23 Siwa有限公司 用于治疗炎症和自身免疫紊乱的抗age抗体
US10358502B2 (en) 2014-12-18 2019-07-23 Siwa Corporation Product and method for treating sarcopenia
US9993535B2 (en) 2014-12-18 2018-06-12 Siwa Corporation Method and composition for treating sarcopenia
WO2018191718A1 (en) 2017-04-13 2018-10-18 Siwa Corporation Humanized monoclonal advanced glycation end-product antibody
WO2017143073A1 (en) 2016-02-19 2017-08-24 Siwa Corporation Method and composition for treating cancer, killing metastatic cancer cells and preventing cancer metastasis using antibody to advanced glycation end products (age)
CA3057829A1 (en) 2016-04-15 2017-10-19 Siwa Corporation Anti-age antibodies for treating neurodegenerative disorders
JP2019518763A (ja) 2016-06-23 2019-07-04 シワ コーポレーション 様々な疾患及び障害の治療において使用するためのワクチン
US10925937B1 (en) 2017-01-06 2021-02-23 Siwa Corporation Vaccines for use in treating juvenile disorders associated with inflammation
US10858449B1 (en) 2017-01-06 2020-12-08 Siwa Corporation Methods and compositions for treating osteoarthritis
US10995151B1 (en) 2017-01-06 2021-05-04 Siwa Corporation Methods and compositions for treating disease-related cachexia
US10961321B1 (en) 2017-01-06 2021-03-30 Siwa Corporation Methods and compositions for treating pain associated with inflammation
US11518801B1 (en) 2017-12-22 2022-12-06 Siwa Corporation Methods and compositions for treating diabetes and diabetic complications

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744300A (en) * 1993-03-24 1998-04-28 Geron Corporation Methods and reagents for the identification and regulation of senescence-related genes
US5580726A (en) * 1994-04-29 1996-12-03 Geron Corporation Method and Kit for enhanced differential display
WO1999007850A1 (en) * 1997-08-06 1999-02-18 Millennium Biotherapeutics, Inc. Tango-71, tango-73, tango-74, tango-76, and tango-83 nucleic acid molecules and polypeptides
ES2312205T3 (es) * 1998-03-10 2009-02-16 Genentech, Inc. Nuevo polipeptido y acidos nucleicos que lo codifican.
CA2332379A1 (en) * 1998-06-29 2000-01-06 Incyte Pharmaceuticals, Inc. Molecules associated with apoptosis

Also Published As

Publication number Publication date
EP1012333A4 (de) 2003-01-02
WO1999007893A1 (en) 1999-02-18
JP2001512698A (ja) 2001-08-28
AU8693598A (en) 1999-03-01
EP1012333A1 (de) 2000-06-28
BR9811865A (pt) 2000-08-15
TR200000331T2 (tr) 2000-05-22
CN1270637A (zh) 2000-10-18
CA2296598A1 (en) 1999-02-18

Similar Documents

Publication Publication Date Title
KR20010022741A (ko) 신규 노화-인자 유전자, ｐ23의 단리
CA2665489C (en) Prrg4-associated compositions and methods of use thereof in methods of tumor diagnosis
Fernandez-Pol et al. A growth factor-inducible gene encodes a novel nuclear protein with zinc finger structure.
US20060035329A1 (en) Human hairless gene and protein
JP2003508030A (ja) 新規ポリペプチドおよびそれをコードする核酸
US5807740A (en) Regulators of UCP2 gene expression
Haag et al. Structure of the gene encoding the rat T cell ecto-ADP-ribosyltransferase RT6.
US6987004B1 (en) Genes integrating signal transduction pathways
Fiucci et al. Genomic organization and expression of mouse Tpt1 gene☆
US20080248009A1 (en) Regulation of acheron expression
US20050196753A1 (en) Human coactivator-associated arginine methyltransferase 1 (hCARM1)
CN100352842C (zh) 对促肾上腺皮质激素释放激素刺激的应答而表达增加的基因
CA2319037A1 (en) Identification of factors which mediate the interaction of heterotrimeric g proteins and monomeric g proteins
CA2325663A1 (en) Novel mutations in the freac3 gene for diagnosis and prognosis of glaucoma and anterior segment dysgenesis
US20030148270A1 (en) Genes from the 20q13 amplicon and their uses
Mykkänen et al. Promoter analysis of the human SLC7A7 gene encoding y+ L amino acid transporter-1 (y+ LAT-1)
US7309783B2 (en) Mammalian early developmental regulator gene
JP2004500825A (ja) Ｋｃｎｂ：新規なカリウムチャネルタンパク質
JP2001512007A (ja) Ｚｇｇｂｐ１、１型双極性感情障害に関与する新規ペプチド、配列及びその使用
US20060252680A1 (en) Genes whose expression is increased in response to stimulation by corticotropin-releasing hormone
US20020123092A1 (en) Regulatory elements from RP1 gene and uses thereof
JP2000152792A (ja) 新規ｇ蛋白質共役型受容体蛋白質、ｄｎａおよびその用途
Mattei et al. Human CREM Gene: Evolutionary Conservation, Chromosomal Localization, and Inducibility of the Transcript’
US20030105001A1 (en) Pro-apoptotic proteins and DNA molecules encoding them
EP1558639A2 (de) Gene, deren expression auf grund der stimulation durch den corticotropinfreisetzende-faktor erhöht wird

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid